Navigation Links
Electrospinning: Emerging New Technology at Zeus
Date:2/16/2009

Zeus is developing new technology in the field of electrospinning for applications primarily within the medical device and filtration industries

ORANGEBURG, S.C., Feb. 16 /PRNewswire/ -- Zeus, Inc. announces a new technology platform in the field of electrospinning, a process that produces polymer fibers with thicknesses ranging from the nano to microscale. Zeus is able to develop fabrics with complex shapes from solutions, pastes, and bioabsorbables. The result is a broad range of fiber and fabric properties that are able to meet some of the most challenging demands.

Electrospun polymers produce fibers and fabrics with high surface to weight and volume ratios, which makes these materials excellent candidates for controlled biological interactions and filtration media (stand alone and coding).

In the biological area, the porous nature of the fabric allows for the formation of implantable structures within the body. Cellular growth is allowed as the electrospun fabric acts as a scaffolding to permit integration into the body. In the case of bioabsorbable materials, the scaffolding is eventually absorbed, leaving a structure of the body's own cells intact. To meet application demands, Zeus is able to introduce additives, ranging from therapeutic agents to property modifiers, into the solutions that are then incorporated into the fibers and fabrics.

"Embarking on this new technology platform demonstrates Zeus' long-standing commitment to innovation, research, and superior customer support," said Bruce Anneaux, Corporate Manager, Research and Development. "We are excited about the electrospinning process and what this means for our partners in terms of enhancing and creating new solutions for challenging applications."

About Zeus, Inc.:

Zeus, Inc. is headquartered in Orangeburg, SC, USA. Zeus is a world leader in the design and production of high-performance polymer tubing used in demanding applications, operating multiple facilities in North America and internationally. Zeus products and services are preferred by companies in medical, automotive, electrical, fluid handling, and mechanical markets. For more information, visit http://www.zeusinc.com.

    Press Contact:

    Samantha D. Farlow
    (803) 268-9500

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Zeus, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
2. Favrille to Present at AG Edwards Emerging Growth Conference and Wall Street Analyst Forum
3. Bionovo to Present at A.G. Edwards 2nd Annual Emerging Growth Conference 2007
4. Kensey Nash to Present at the Sidoti Sixth Annual West Coast Emerging Growth Institutional Investor Forum Conference
5. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
6. Neurocrine Biosciences to Present at the A.G. Edwards Annual Emerging Growth Conference
7. Luminex Corporation to Present at Americas Growth Capital Emerging Growth Conference
8. Project on Emerging Nanotechnologies and Consumers Union collaborate on ConsumersTalkNano
9. NanoMaterials Technology to Conduct Process Development Feasibility Study with US Based Emerging Pharmaceutical Company
10. Clarient CEO Ron Andrews to Participate in OneMedPlace Emerging Healthcare Technologies Finance Forum
11. Kensey Nash to Participate in the Sidoti Fifth Annual Palm Beach Emerging Growth Institutional Investor Forum Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 23, 2017  Northwest Biotherapeutics (OTCQB: NWBO) (NW ... therapies for solid tumor cancers, today announced that ... it announced last Friday, March 17, 2017. ... investors securities totaling 28,843,692 shares, comprised of 18,843,692 ... shares of Class C Warrants pre-funded at the ...
(Date:3/23/2017)... PARK, Calif., March 23, 2017  BioPharmX Corporation ... products for the dermatology market, today reported financial ... 31, 2017, and will provide an update on ... the year. "We are pleased to ... year for BioPharmX," said President Anja Krammer. "We ...
(Date:3/23/2017)... 2017 NetworkNewsWire Editorial Coverage  ... Cancer remains one ... on health care systems, in terms of costs and resources. ... does the development of innovative and efficient therapies that demonstrate ... many types of cancer treatments, a growing number of patients ...
(Date:3/23/2017)... In today,s pre-market research, Stock-Callers.com ... Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate Pharmaceuticals ... and Regulus Therapeutics Inc. (NASDAQ: RGLS ). ... its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn more ... ...
Breaking Biology Technology:
(Date:2/21/2017)... , February 21, 2017 Der ... US-Dollar wachsen. Nach einem Gespräch mit mehr als 50 Vertretern ... Hindernisse zu überwinden gilt, um diese Prognose zu realisieren. ... ... die Mobilisierung der finanziellen Mittel für die Biobank, die ...
(Date:2/14/2017)... Feb. 14, 2017  Wake Forest Baptist Medical Center ... new chief executive officer (CEO). Freischlag joins the medical ... D. McConnell , M.D., who last year announced that ... Medical Center, after leading it since 2008.   ... of Wake Forest Baptist,s academic health system, which includes ...
(Date:2/13/2017)... -- Former 9/11 Commission border counsel and Special Counsel ... of Identity Strategy Partners, LLP, today releases the ... Order: Protecting the Nation From Foreign Terrorist Entry Into ... President Trump,s ,Travel Ban, Executive Order gains more notoriety ... travel ban, it is important that our national discourse ...
Breaking Biology News(10 mins):